An anti-cancer drug used to fight leukemia shows promise against a rare and aggressive type of ovarian cancer – small cell carcinoma of the ovary hypercalcemic type (SCCOHT) – which strikes young women and girls, according to a new study. Ponatinib was found in TGen-led drug screens and preclinical studies to significantly delay tumor growth and reduce tumor volume in SCCOHT.
from Top Health News – ScienceDaily http://bit.ly/2F9hWS2
from Tumblr http://bit.ly/2oKDJIV
No comments:
Post a Comment